These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5964610)

  • 1. The biology of large solid tumours regressing with nitrogen mustard treatment: a study of the mouse plasma cell tumour Adj-pc-5 and the Walker carcinosarcoma 256.
    Goldacre RJ; Whisson ME
    Br J Cancer; 1966 Dec; 20(4):801-12. PubMed ID: 5964610
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduction of the toxicity of radiomimetic alkylating agents in rats by thiol pretreatment. V. The effect of thiol pretreatment on the anti-tumour action of Merophan.
    Connors TA; Jenney A; Whisson ME
    Biochem Pharmacol; 1965 Nov; 14(11):1681-3. PubMed ID: 5867521
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cytostatic effect of 1-methyl-2-(p-(bis-(beta-chlorethyl)-amino)-phenyliminomethyl)-quinolinium chloride (IMET 3106) on the growth of transplantable neoplasms].
    Jungstand W; Gutsche W; Wohlrabe K
    Arch Geschwulstforsch; 1972; 40(1):35-9. PubMed ID: 4510766
    [No Abstract]   [Full Text] [Related]  

  • 4. Cure of mice bearing advanced plasma cell tumours with aniline mustard.
    Whisson ME; Connors TA
    Nature; 1965 May; 206(985):689-91. PubMed ID: 5832853
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug resistance study in a mixed nitrogen mustard-sensitive-resistant tumour.
    Ujházy V
    Neoplasma; 1969; 16(4):467-8. PubMed ID: 5344233
    [No Abstract]   [Full Text] [Related]  

  • 6. 2,4-dinitro-5-ethyleneiminobenzamide (CB 1954): a potent and selective inhibitor of the growth of the Walker carcinoma 256.
    Cobb LM; Connors TA; Elson LA; Khan AH; Mitchley BC; Ross WC; Whisson ME
    Biochem Pharmacol; 1969 Jun; 18(6):1519-27. PubMed ID: 4307990
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cytostatic effect of vinylogous nitrogen mustard carbonamidium salts against transplanted tumors in an automatic preliminary test and a sequential test program].
    Gutsche W; Jungstand W; Wohlrabe K; Fischer GW; Lohs K
    Arch Geschwulstforsch; 1972; 39(2):121-7. PubMed ID: 5065117
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental findings concerning the antineoplastic drug fluordopan].
    Larionov LF; Bukharova IK
    Vopr Onkol; 1971; 17(5):78-81. PubMed ID: 4333111
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental animal studies on the regional perfusion of tumors of the extremities].
    Brock N; Niekamp T
    Arzneimittelforschung; 1968 Jan; 18(1):1-7. PubMed ID: 5754938
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential anticancer angents. II. Schiff bases from benzaldehyde nitrogen mustards.
    Dhapalapur MG; Sabnis SS; Deliwala CV
    J Med Chem; 1968 Sep; 11(5):1014-9. PubMed ID: 5697061
    [No Abstract]   [Full Text] [Related]  

  • 11. Some serum protein nitrogen mustard complexes with high chemotherapeutic selectivity.
    Wade R; Whisson ME; Szerkerke M
    Nature; 1967 Sep; 215(5107):1303-4. PubMed ID: 6052739
    [No Abstract]   [Full Text] [Related]  

  • 12. [Role of immunity in the action of sarcolysine and other preparations].
    Syrkin AB; Solenov VN; Bodiagin DA; Zaĭtseva LA
    Vestn Akad Med Nauk SSSR; 1971; 26(3):55-9. PubMed ID: 5581445
    [No Abstract]   [Full Text] [Related]  

  • 13. [In vitro and in vivo experiments on multiple-step cancer therapy; attack induction by alkylating cytostatics].
    von Ardenne M; Chaplain RA; Reitnauer PG
    Dtsch Gesundheitsw; 1969 Sep; 24(38):1781-7. PubMed ID: 5376244
    [No Abstract]   [Full Text] [Related]  

  • 14. Potential anticancer agents. V. New aromatic nitrogen mustards related to 3-[N,N-bis(2-chloroethyl)amino]-4-methylbenzoic acid.
    Cambanis A; Dobre V; Niculescu-Duvăz I
    J Med Chem; 1969 Jan; 12(1):161-4. PubMed ID: 5763014
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of cure of large plasma cell tumors.
    Whisson ME; Connors TA; Jeney A
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):825-31. PubMed ID: 5958003
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of chemical agents against the plasma cell tumor LPC-1 in mice.
    Abraham D; Carbone PP; Venditti JM; Kline I; Goldin A
    Biochem Pharmacol; 1967 Apr; 16(4):665-73. PubMed ID: 6033787
    [No Abstract]   [Full Text] [Related]  

  • 17. Potential carcinolytic agents. V. Enamine mustards.
    Papanastassiou ZB; Bruni RJ; White E
    J Med Chem; 1967 Jul; 10(4):701-6. PubMed ID: 6037064
    [No Abstract]   [Full Text] [Related]  

  • 18. Some antitumor agents derived from benzaldehyde nitrogen mustards.
    Florvall L
    Acta Pharm Suec; 1970 Apr; 7(2):87-104. PubMed ID: 5421623
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative study of cyclophosphamide, ifosfamide and trofosfamide on Walker-256 carcinosarcoma in embryonated chicken eggs].
    Norpoth K; Witting U; Rauen HM
    Arzneimittelforschung; 1974 Jan; 24(1):86-9. PubMed ID: 4406116
    [No Abstract]   [Full Text] [Related]  

  • 20. [Time factor in evaluating antineoplastic agents].
    Syrkin AB
    Farmakol Toksikol; 1972; 35(1):75-9. PubMed ID: 5011523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.